Showing 1 - 14 results of 14 for search 'Alessandro Pulsoni', query time: 0.04s
Refine Results
-
1
-
2
INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY by Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni
Published 2016-01-01
Article -
3
-
4
-
5
Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target by Alberto Quattrocchi, Luca Vincenzo Cappelli, Giovanna De Simone, Elisabetta De Marinis, Martina Gentile, Tecla Gasperi, Alessandro Pulsoni, Paolo Ascenzi, Clara Nervi
Published 2023-12-01
Article -
6
Response to Interferon-Free Direct Antivirals (DAAS) Treatment in HCV-Related Subcutaneous Lipoma-Like Marginal Zone B-Cell Lymphoma by Maria Lucia De Luca, Laura Lombardi, Germana Tartaglia, Francesca Fazio, Alessio Di Prima, Laura Cesini, Alessandra Serrao, Martina Canichella, Alessandro Pulsoni
Published 2019-08-01
Article -
7
MRI versus CT and PET/CT in the Preoperative Assessment of Hodgkin and Non-Hodgkin Lymphomas by Francesca Maccioni, Alessandro Calabrese, Lucia Manganaro, Carlo de Felice, Sara Cardaccio, Mariangela Lopez, Arianna Cleri, Gabriela Capriotti, Luigi Petrucci, Carlo Catalano, Alessandro Pulsoni
Published 2021-10-01
Article -
8
High Basal Maximal Standardized Uptake Value (SUV<sub>max</sub>) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse by Giovanni Manfredi Assanto, Giulia Ciotti, Mattia Brescini, Maria Lucia De Luca, Giorgia Annechini, Gianna Maria D’Elia, Roberta Agrippino, Ilaria Del Giudice, Maurizio Martelli, Agostino Chiaravalloti, Alessandro Pulsoni
Published 2021-06-01
Article -
9
S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES by Giovanni Manfredi Assanto, Martina Salvatori, Sara Pontecorvo, Gianluca Maiorana, Natalia Cenfra, Gianna Maria D’elia, Maria Paola Bianchi, Giorgia Annechini, Cristina Santoro Santoro, Maurizio Martelli, Agostino Tafuri, Alessandro Pulsoni, Ilaria Del Giudice, Antonio Chistolini
Published 2023-08-01
Article -
10
Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin’s disease by Mariavita Ciccarone, Mariavita Ciccarone, Paola Cavaceppi, Paola Cavaceppi, Cristiano Tesei, Stefania Brunetti, Alessandro Pulsoni, Ombretta Annibali, Cristiano Gasparoli, Roberta Battistini, Stefan Hohaus, Sabrina Pelliccia, Agostino Tafuri, Maria Christina Cox, Maria Cantonetti, Luigi Rigacci, Elisabetta Abruzzese
Published 2023-04-01
Article -
11
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study by Livio Pagano, Marianna Criscuolo, Alessandro Broccoli, Alfonso Piciocchi, Marzia Varettoni, Eugenio Galli, Antonella Anastasia, Maria Cantonetti, Livio Trentin, Sofia Kovalchuk, Lorella Orsucci, Annamaria Frustaci, Angelica Spolzino, Stefano Volpetti, Ombretta Annibali, Sergio Storti, Caterina Stelitano, Francesco Marchesi, Massimo Offidani, Beatrice Casadei, Maria Elena Nizzoli, Maria Lucia De Luca, Luana Fianchi, Marina Motta, Luca Guarnera, Edoardo Simonetti, Andrea Visentin, Francesco Vassallo, Marina Deodato, Chiara Sarlo, Attilio Olivieri, Brunangelo Falini, Alessandro Pulsoni, Enrico Tiacci, Pier Luigi Zinzani
Published 2022-07-01
Article -
12
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatmentResearch in context by Luca Arcaini, Côme Bommier, Juan Pablo Alderuccio, Michele Merli, Nicole Fabbri, Maria Elena Nizzoli, Matthew J. Maurer, Vittoria Tarantino, Simone Ferrero, Sara Rattotti, Annalisa Talami, Roberta Murru, Arushi Khurana, Raphael Mwangi, Marina Deodato, Emanuele Cencini, Francesca Re, Carlo Visco, Andrew L. Feldman, Brian K. Link, Marcia Torresan Delamain, Michele Spina, Ombretta Annibali, Alessandro Pulsoni, Andrés J.M. Ferreri, Caterina Cecilia Stelitano, Elsa Pennese, Thomas M. Habermann, Luigi Marcheselli, Sunwoo Han, Isildinha M. Reis, Marco Paulli, Izidore S. Lossos, James R. Cerhan, Stefano Luminari
Published 2024-06-01
Article -
13
P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTENSIVE CHEMOTHERAPY IMPACTS ON THE LEVEL OF POST-CONSOLIDATION MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA by Adriano Venditti, Alfonso Piciocchi, Luca Maurillo, Maria Ilaria Del Principe, Raffaele Palmieri, Stefano Soddu, Federico Moretti, Prassede Salutari, Maurizio Martelli, Maria Paola Martelli, Mario Luppi, Alessandro Pulsoni, Francesco Zaja, Roberto Cairoli, Fabrizio Pane, Sergio Siragusa, Renato Bassan, Michela Rondoni, Milena Mirabile, Antonino Mulè, Germana Beltrami, Patrizia Zappasodi, Laura Cudillo, Andrea Mengarelli, Antonio Curti, Felicetto Ferrara, Giovanni Rossi, Ernesta Audisio, Giuseppina Spinosa, Alessia Tieghi, Monica Bocchia, Vincenza Martini, Catello Califano, Luigi Rigacci, Agostino Tafuri, Michele Gottardi, Paola Fazi, Marco Vignetti, Francesco Buccisano
Published 2023-08-01
Article -
14
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi by Manuel Gotti, Roberta Sciarra, Alessandro Pulsoni, Francesco Merli, Stefano Luminari, Caterina Zerbi, Livio Trentin, Alessandro Re, Chiara Rusconi, Simonetta Viviani, Andrea Rossi, Federica Cocito, Barbara Botto, Erika Meli, Antonello Pinto, Irene Dogliotti, Guido Gini, Benedetta Puccini, Francesca Ricci, Luca Nassi, Alberto Fabbri, Anna Marina Liberati, Michele Merli, Andrea Riccardo Filippi, Maurizio Bonfichi, Valentina Zoboli, Germana Tartaglia, Giorgia Annechini, Gianna Maria D’Elia, Ilaria Del Giudice, Isabel Alvarez, Andrea Visentin, Stefano Pravato, Daniela Dalceggio, Chiara Pagani, Silvia Ferrari, Caterina Cristinelli, Tanja Lazic, Virginia Valeria Ferretti, Umberto Ricardi, Luca Arcaini
Published 2023-04-01
Article